Brian Low Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
8,768
+1,118
+15% +$241K 1.29% 21
2026
Q1
$1.66M Buy
7,650
+631
+9% +$140K 1.13% 24
2025
Q4
$1.6M Buy
7,019
+552
+9% +$126K 1.14% 21
2025
Q3
$1.5M Buy
6,467
+1,471
+29% +$300K 1.16% 17
2025
Q2
$927K Buy
+4,996
New +$928K 0.87% 30

Other funds holding ABBV

Brian Low Financial Group's ABBV Position: Q2 2026 in Review

Brian Low Financial Group increased its AbbVie (ABBV) stake by 15% in Q2 2026, buying an estimated $241K and bringing the position to 8,768 shares worth $2.21M. The position accounts for 1.29% of the portfolio, ranked #21.

Brian Low Financial Group first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brian Low Financial Group held 8,768 shares of AbbVie worth $2.21M as of Q2 2026.
  • Brian Low Financial Group bought 1,118 AbbVie shares in Q2 2026, an estimated $241K.
  • AbbVie made up 1.29% of Brian Low Financial Group's portfolio in Q2 2026, its #21 holding.
  • Brian Low Financial Group first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brian Low Financial Group's 13F filing for Q2 2026, filed 28 Jul 2026.